We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Drug Screen for Acetaminophen

By HospiMedica staff writers
Posted on 11 Mar 2005
A novel, rapid point-of-care (POC) diagnostic test detects acetaminophen in urine. More...
Called Triage TOX drug screen, the test has been cleared by the U.S. Food and Drug Administration (FDA).

Overdose from acetaminophen is the leading cause for calls to the U.S. Poison Control Centers and is estimated to represent 5% (275,000) of the 5.2 million U.S. total toxic exposures annually. Acetaminophen is one of the most widely used analgesics in the world and is found in more than 100 common over-the-counter and prescription products. While the drug has an excellent safety profile, toxicity can occur after intentional overdose or acute ingestion of 150-250 mg per kg of body weight.

According to the U.S. National Academy of Clinical Biochemistry guidelines, every patient suspected of intentional drug ingestion should be screened for acetaminophen in one hour or less,” noted Ken Buechler, Ph.D., president and chief scientific officer of Biosite Incorporated (San Diego, CA, USA), which developed the test.
"Because the Triage TOX drug screen uses the Triage MeterPlus platform, which produces results in approximately 15 minutes at the point of care, we believe it can improve turnaround time for acetaminophen.”

The company is offering three different combinations of analytes to cover the eight major classes of drugs. The tests will be available in English-speaking countries worldwide and in other countries upon approval by local regulatory agencies.






Related Links:
Biosite

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Patient Monitoring System
AlarmSense
Resorbable Bovine Collagen Membrane
GenDerm
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new, inexpensive stick-on sweat sensor measures lipid levels, offering a noninvasive way to continuously monitor cholesterol and triglycerides. (Image Credit: California Institute of Technology)

Wearable Patch Enables Continuous Noninvasive Cholesterol and Triglyceride Monitoring

Cholesterol and triglyceride testing typically relies on phlebotomy and intermittent lipid panels, limiting real-time assessment of cardiovascular and metabolic risk. Noninvasive monitoring could reduce... Read more

Surgical Techniques

view channel
Image: Phasix Mesh is a fully resorbable monofilament scaffold designed for rapid tissue incorporation, combining synthetic mesh repair strength with biologic graft-like remodeling. (Photo courtesy of BD)

Resorbable Mesh Evaluated to Prevent Incisional Hernias After Abdominal Surgery

Incisional hernia is a common complication after abdominal surgery and can necessitate additional interventions and prolonged recovery. Preventive strategies remain limited, and there are currently no... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.